DOLOMITE Corp Bhd expects its new joint-venture company Dolomite Biotech Sdn Bhd, which deals in disposable safety syringes, to start contributing to group profits by the second quarter of next year, said executive vice-chairman Lim Beng Keat.
“We should see an impact on profits once manufacturing and distribution of the syringes start next year. It should be substantial,” he said at a media briefing in Kuala Lumpur yesterday.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
